These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30538219)

  • 21. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal-activated invariant T cells do not exhibit significant lung recruitment and proliferation profiles in macaques in response to infection with Mycobacterium tuberculosis CDC1551.
    Bucsan AN; Rout N; Foreman TW; Khader SA; Rengarajan J; Kaushal D
    Tuberculosis (Edinb); 2019 May; 116S():S11-S18. PubMed ID: 31072689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis.
    Sharma S; Sharma M; Roy S; Kumar P; Bose M
    Immunol Cell Biol; 2004 Aug; 82(4):377-82. PubMed ID: 15283847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients.
    Lee ES; Park CM; Goo JM; Yim JJ; Kim HR; Lee HJ; Lee IS; Im JG
    J Comput Assist Tomogr; 2010 Jul; 34(4):559-63. PubMed ID: 20657225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.
    Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B
    Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exogenous re-infection in tuberculosis].
    Tsuchiya T
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Factors for Multidrug-resistant Tuberculosis.
    Rumende CM
    Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.
    McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM
    Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphoantigen/IL2 expansion and differentiation of Vγ2Vδ2 T cells increase resistance to tuberculosis in nonhuman primates.
    Chen CY; Yao S; Huang D; Wei H; Sicard H; Zeng G; Jomaa H; Larsen MH; Jacobs WR; Wang R; Letvin N; Shen Y; Qiu L; Shen L; Chen ZW
    PLoS Pathog; 2013 Aug; 9(8):e1003501. PubMed ID: 23966854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity.
    Dijkman K; Vervenne RAW; Sombroek CC; Boot C; Hofman SO; van Meijgaarden KE; Ottenhoff THM; Kocken CHM; Haanstra KG; Vierboom MPM; Verreck FAW
    Front Immunol; 2019; 10():2479. PubMed ID: 31736945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.
    da Costa AC; Costa-Júnior Ade O; de Oliveira FM; Nogueira SV; Rosa JD; Resende DP; Kipnis A; Junqueira-Kipnis AP
    PLoS One; 2014; 9(11):e112848. PubMed ID: 25398087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation.
    Ocaña-Guzman R; Tellez-Navarrete NA; Preciado-Garcia M; Ponce-Gallegos MA; Buendia-Roldan I; Falfán-Valencia R; Chavez-Galan L
    Microb Pathog; 2021 Apr; 153():104793. PubMed ID: 33582220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli.
    Zhao JN; Zhang XX; He XC; Yang GR; Zhang XQ; Li HC
    PLoS One; 2015; 10(7):e0134998. PubMed ID: 26230499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.
    Shanmugasundaram U; Bucsan AN; Ganatra SR; Ibegbu C; Quezada M; Blair RV; Alvarez X; Velu V; Kaushal D; Rengarajan J
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32554933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
    Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
    Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.
    de Araújo-Filho JA; Vasconcelos AC; Martins de Sousa E; Kipnis A; Ribeiro E; Junqueira-Kipnis AP
    Tuberculosis (Edinb); 2008 Sep; 88(5):474-81. PubMed ID: 18676203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study.
    Yunusbaeva M; Borodina L; Alekseev P; Davydov R; Yunusbaev U; Sharipov R; Bilalov F; Yunusbayev B
    Int J Infect Dis; 2019 Apr; 81():203-209. PubMed ID: 30794942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T Cells Subvert Mycobacterial Containment in Patients Failing Extensively Drug-Resistant Tuberculosis Treatment.
    Davids M; Pooran AS; Pietersen E; Wainwright HC; Binder A; Warren R; Dheda K
    Am J Respir Crit Care Med; 2018 Jul; 198(1):104-116. PubMed ID: 29425052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.